08:00 , Jan 20, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Cardiovascular disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Myocardial infarction (MI) MicroRNA-499 (miR-499) In vitro and mouse studies suggest that increasing miR-499 activity in the heart could improve...